We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XXII
826
22nd Century Group
XXII
$1.28M
| – | – |
0
| – | – |
|
827
Verastem
VSTM
$528M
| $434K | ﹤0.01% |
29,917
+27,834
| +1,336% | +$461K |
|
828
SmartFinancial
SMBK
$906M
| $428K | ﹤0.01% |
31,469
-5,956
| -16% | -$84.2K |
|
|
FNHC
829
DELISTED
FedNat Holding Company Common Stock
FNHC
| $428K | ﹤0.01% |
67,755
-53,383
| -44% | -$483K |
|
830
Sally Beauty Holdings
SBH
$1.47B
| $427K | ﹤0.01% |
+49,147
| New | +$591K |
|
|
AGEN
831
Agenus
AGEN
$276M
| $425K | ﹤0.01% |
5,413
-571
| -10% | -$44.4K |
|
832
Matador Resources
MTDR
$6.04B
| $425K | ﹤0.01% |
51,441
+24,218
| +89% | +$217K |
|
|
MTSC
833
DELISTED
MTS Systems Corp
MTSC
| $425K | ﹤0.01% |
22,248
+7,266
| +48% | +$152K |
|
834
Donegal Group Class A
DGICA
$715M
| $424K | ﹤0.01% |
30,153
-4,922
| -14% | -$70.2K |
|
835
Alaska Air
ALK
$5.11B
| $423K | ﹤0.01% |
11,540
-2,076
| -15% | -$77.8K |
|
836
Idexx Laboratories
IDXX
$44.9B
| $423K | ﹤0.01% |
1,077
| – | – |
|
|
SREV
837
DELISTED
ServiceSource International, Inc.
SREV
| $420K | ﹤0.01% |
285,974
+45,587
| +19% | +$70.4K |
|
|
GRTS
838
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $418K | ﹤0.01% |
157,860
+135,847
| +617% | +$504K |
|
839
Camden National
CAC
$988M
| $409K | ﹤0.01% |
13,545
-5,630
| -29% | -$182K |
|
|
CNR
840
Core Natural Resources Inc
CNR
$3.93B
| $409K | ﹤0.01% |
92,264
+2,068
| +2% | +$10.8K |
|
|
ZNGA
841
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $401K | ﹤0.01% |
44,000
-3,800
| -8% | -$35.4K |
|
842
Liberty Media Series A
FWONA
$23.4B
| $398K | ﹤0.01% |
12,418
-607
| -5% | -$19.7K |
|
843
Quad
QUAD
$479M
| $398K | ﹤0.01% |
131,315
+29,027
| +28% | +$96K |
|
|
UBX
844
DELISTED
Unity Biotechnology
UBX
| $397K | ﹤0.01% |
11,488
-13,537
| -54% | -$857K |
|
845
Geospace Technologies
GEOS
$84M
| $396K | ﹤0.01% |
64,002
+14,324
| +29% | +$97.8K |
|
846
Hope Bancorp
HOPE
$1.8B
| $394K | ﹤0.01% |
+51,974
| New | +$435K |
|
|
GNMK
847
DELISTED
GenMark Diagnostics, Inc
GNMK
| $393K | ﹤0.01% |
27,701
-35,528
| -56% | -$543K |
|
|
SMAR
848
DELISTED
Smartsheet Inc.
SMAR
| $389K | ﹤0.01% |
+7,880
| New | +$380K |
|
|
GNTY
849
DELISTED
Guaranty Bancshares
GNTY
| $388K | ﹤0.01% |
17,145
-2,164
| -11% | -$51K |
|
850
Jacobs Solutions
J
$16B
| $388K | ﹤0.01% |
5,058
-295
| -6% | -$21.6K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.